Fundz

Uruguayan biotech Xeptiva raised $2.5M in a seed round led by Zentynel to develop veterinary vaccines for pets.

PRIVATEOct 02, 2024

Amount Raised

$2.5 Million

Round Type

Seed

MontevideoBiotechnologyHealth CareTherapeutics

Investors

Fen VenturesZentynelSergio FogelUruguay Biotech VenturesiThink VCNd Latam

Description

Biotech Xeptiva raised a $2.5M seed round to continue developing vaccines for osteoarthritis pain and atopic dermatitis in pets. The round was led by Zentynel, with participation from several other investors.

Quick answer

Xeptiva raised $2.5 Million in a Seed round, dated October 2, 2024. Investors: Fen Ventures, Zentynel, Sergio Fogel, Uruguay Biotech Ventures, iThink VC and Nd Latam. Xeptiva is based in Montevideo, Montevideo, Uruguay.

How much did Xeptiva raise?
Xeptiva raised $2.5 Million in a Seed round on October 2, 2024.
Who invested in Xeptiva?
Fen Ventures, Zentynel, Sergio Fogel, Uruguay Biotech Ventures, iThink VC and Nd Latam are named as investors in this round.
What does Xeptiva do?
Xeptiva Therapeutics develops and produces vaccines to treat chronic inflammatory conditions in pets.
Where is Xeptiva based and how big is it?
Xeptiva is based in Montevideo, Montevideo, Uruguay. Fundz records about 10 employees.
Who are the decision-makers at Xeptiva?
Fundz holds 1 contact at Xeptiva. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Xeptiva that raised within 45 days of this round, from Fundz verified event records.

  • TRex Bio raised $84M (Series B) on November 13, 2024.
  • Phlox Therapeutics raised $2M (Seed) on November 13, 2024.
  • Hyku Biosciences raised $64M (Seed) on November 12, 2024.
  • Zucara Therapeutics raised $20M (Series B) on November 12, 2024.
  • Strata Oncology raised $6.1M on November 8, 2024.
  • TRex Bio raised $42M on November 7, 2024.

Who to call at Xeptiva, and when

A new round usually means Xeptiva is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xeptiva raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xeptiva, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xeptiva. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xeptiva

Location

Montevideo, Montevideo, Uruguay

About

Xeptiva Therapeutics develops and produces vaccines to treat chronic inflammatory conditions in pets. The company focuses on increasing access to effective treatments for conditions such as osteoarthritis pain and atopic dermatitis. Founded in 2021, Xeptiva is currently conducting clinical trials for its vaccines. Its first batch of vaccines was produced in 2024.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xeptiva raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Xeptiva's next move

See what Strategic adds

Xeptiva raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.